LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates
Expanded agreement grants Iksuda access to Legochem Biosciences’ next generation ADC platform for up
Expanded agreement grants Iksuda access to Legochem Biosciences’ next generation ADC platform for up
Funding to accelerate clinical progression of Iksuda’s pipeline of new generation of antibody drug
Alcyomics are one of four businesses based in The Biosphere that received a share
A £210m national flagship science and healthcare project, to be delivered from the North
A technology-driven spin out that looks to transform cell production is the latest business
A digital transformation company, who help businesses to transform productivity through digitalisation have opened
Healthcare marketing communications specialists Onyx Health have strengthened their growing team with five new
North East university partnership Northern Accelerator has made over £500,000 worth of investments into
A biotech start-up, whose technology aims to tackle donor tissue shortages and speed up
AMLo Biosciences Ltd (AMLo) has gained significant new investments totalling £1.5m, from: funds managed